Diabetic Foot Ulcers: ICD-10 Codes, Wagner Classification & Evidence-Based Wound Care

Quick answer: Diabetic foot ulcers in Type 2 diabetes are coded E11.621 (ICD-10), with an additional L97.4x/L97.5x code for the wound site. The Wagner Grade determines severity (0–5); IWGDF 2023 recommends total contact casting for offloading and moist wound healing with antimicrobials for infected wounds.

Why Are Diabetic Foot Ulcers a Critical Clinical Priority in Singapore?

Singapore has one of the highest diabetes prevalence rates in the Asia-Pacific region. The MOH National Population Health Survey 2022 estimates that 8.8% of Singapore residents aged 18–69 have diabetes, with a significantly higher prevalence among the Indian community (~17%) and Malay community (~12%). Diabetic foot ulcers (DFUs) affect up to 25% of people with diabetes during their lifetime and are the leading cause of non-traumatic lower limb amputation.

Specialist diabetic foot services operate at Singapore General Hospital (SGH), National University Hospital (NUH), Alexandra Hospital, Changi General Hospital (CGH), and Tan Tock Seng Hospital (TTSH). Private facilities including Mount Elizabeth Hospital, Gleneagles Hospital, and Raffles Hospital also provide podiatry and vascular services. The DEFINITE Care programme at SGH coordinates diabetic foot ulcer care between primary care and tertiary services, reflecting MOH Singapore's commitment to amputation prevention.

ICD-10 Codes for Diabetic Foot Ulcers

ICD-10 Code Description Notes
E11.621 Type 2 diabetes mellitus with foot ulcer Most common; use with L97.4- or L97.5- to specify site
E10.621 Type 1 diabetes mellitus with foot ulcer Use with additional L97 code
E13.621 Other specified diabetes mellitus with foot ulcer Includes post-pancreatectomy, secondary diabetes
L97.401 Non-pressure chronic ulcer of unspecified heel and midfoot, limited to breakdown of skin Code first any associated underlying condition
L97.409 Non-pressure chronic ulcer of unspecified heel and midfoot, unspecified severity Use when severity not documented
L97.411–L97.419 Non-pressure chronic ulcer, right heel and midfoot Suffix 1=skin breakdown, 2=fat layer, 3=necrosis, 4=bone, 9=unspecified
L97.421–L97.429 Non-pressure chronic ulcer, left heel and midfoot Same severity suffixes
L97.501–L97.529 Non-pressure chronic ulcer of other part of foot Includes forefoot, toes
E11.52 Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene Wagner Grade 4–5 with vascular component
E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified Code peripheral neuropathy when present

What Is the Wagner Classification for Diabetic Foot Ulcers?

The Wagner Grading System is a widely used, anatomically based severity classification for diabetic foot ulcers, recognised by the IWGDF 2023 guidelines for certain audit purposes:

Wagner Grade Clinical Description Management Priority
Grade 0 Intact skin; pre-ulcerative lesion; healed ulcer Prevention: footwear, monofilament screening, callus debridement
Grade 1 Superficial ulcer, no subcutaneous involvement Offloading (TCC/removable cast walker), moist wound healing
Grade 2 Deep ulcer penetrating to tendon, capsule, or bone without abscess or osteomyelitis Aggressive offloading, debridement, assess vascularity
Grade 3 Deep ulcer with abscess, osteomyelitis, or joint sepsis Hospitalisation, IV antibiotics, surgical debridement, bone biopsy
Grade 4 Partial foot gangrene (forefoot or heel) Urgent vascular surgery referral; revascularisation or partial amputation
Grade 5 Whole foot gangrene Major amputation or palliative management

University of Texas (UT) Classification System

The University of Texas (UT) Wound Classification System adds infection and ischaemia dimensions to depth grading, providing superior prognostic value:

Stage/Grade Grade 0 Grade 1 Grade 2 Grade 3
A (No infection, no ischaemia) Pre/post-ulcer site Superficial Tendon/capsule Bone/joint
B (Infection) + infection + infection + infection + infection
C (Ischaemia) + ischaemia + ischaemia + ischaemia + ischaemia
D (Both) + both + both + both + both

How Is Peripheral Neuropathy Assessed in Diabetic Foot Care?

Loss of protective sensation (LOPS) is the primary risk factor for diabetic foot ulceration. Key assessment tools recommended by IWGDF 2023 include:

  • 10-gram Semmes-Weinstein Monofilament Test: Applied to 3–10 plantar sites. Inability to feel the 10g monofilament at any site indicates LOPS and significantly elevated ulcer risk.
  • 128 Hz Tuning Fork Vibration Test: Applied to the dorsum of the hallux. Inability to detect vibration indicates large-fibre neuropathy.
  • Ankle Reflex Testing: Absent ankle reflexes suggest peripheral neuropathy.
  • Visual Inspection: Callus, foot deformity (Charcot, hammertoe, hallux valgus), dry skin, fissures, and interdigital maceration indicate elevated risk.

Ankle Brachial Pressure Index (ABPI) for Peripheral Arterial Disease

Peripheral arterial disease (PAD) is present in up to 50% of DFU patients and is associated with poor healing outcomes. ABPI assessment is recommended before compression therapy and for all DFU patients:

  • ABPI 0.9–1.3: Normal; no significant PAD
  • ABPI 0.7–0.9: Mild PAD; monitor; consider vascular referral
  • ABPI 0.5–0.7: Moderate PAD; vascular assessment required
  • ABPI <0.5: Severe PAD; urgent vascular surgery referral (SGH, NUH Vascular Surgery)

Note: ABPI may be falsely elevated in medial artery calcification (common in diabetic patients). Toe brachial pressure index (TBPI) or transcutaneous oxygen pressure (TcPO2) should be used when ABPI is unreliable.

Offloading: The IWGDF Gold Standard Recommendation

Pressure relief (offloading) is the single most important intervention for healing neuropathic plantar DFUs. The IWGDF 2023 guideline recommends:

  1. Total Contact Cast (TCC): Gold standard; irremovable; achieves consistent offloading compliance; demonstrated superior healing rates over all other devices. Used at SGH, NUH, and Alexandra Hospital diabetic foot clinics.
  2. Irremovable Knee-High Walker (cast walker rendered irremovable): Acceptable alternative; similar efficacy to TCC when made irremovable.
  3. Removable Cast Walker (RCW): Second-line option; compliance-dependent; appropriate when TCC is contraindicated (e.g., severe infection, vascular compromise).
  4. Forefoot Relief Shoes: Reduce metatarsal head pressure; less evidence than TCC.

Contraindications to TCC include moderate-to-severe infection, significant ischaemia, and uncontrolled oedema.

How Is Diabetic Foot Infection Classified and Managed?

The IWGDF/IDSA 2023 Infection Guideline classifies diabetic foot infections by clinical severity:

Classification Clinical Features Management
Uninfected No clinical signs of infection No antibiotics; wound care and offloading
Mild Superficial; erythema 0.5–2 cm; no systemic features Oral antibiotics; outpatient management
Moderate Deeper infection or erythema >2 cm; no systemic features; may have lymphangitis Consider hospitalisation; IV antibiotics if oral therapy fails; surgical drainage if needed
Severe Any foot infection with systemic SIRS (fever, leukocytosis, tachycardia, tachypnoea) Immediate hospitalisation; broad-spectrum IV antibiotics; urgent surgical consult

Osteomyelitis should be suspected in all Grade 3 Wagner ulcers. The probe-to-bone test (positive predictive value ~89%) and MRI are key diagnostic tools. Bone biopsy provides definitive diagnosis and guides antibiotic selection.

Evidence-Based Dressing Selection for Diabetic Foot Ulcers

Dressing selection is guided by wound characteristics, infection status, and exudate levels. IWGDF 2023 dressing recommendations:

  • Moist wound healing (uninfected wounds): foam dressings, hydrocolloid dressings, or saline-soaked gauze maintain optimal moisture balance and promote granulation
  • Infected wounds: antimicrobial dressings (silver-containing, iodine-impregnated, or PHMB-based) reduce bacterial bioburden. Systemic antibiotics remain essential for moderate-to-severe infection
  • Biofilm management: Debridement (sharp, enzymatic, or autolytic) combined with antimicrobial dressings targets chronic biofilm
  • Growth factor dressings / advanced therapies: IWGDF 2023 makes a conditional recommendation for sucrose octasulfate dressings (e.g., TLC-NOSF) in neuroischaemic DFUs without severe infection. Platelet-rich plasma (PRP) and autologous leucocyte/platelet/fibrin patches have conditional supportive evidence
  • Negative Pressure Wound Therapy (NPWT): Conditionally recommended for post-operative wounds following diabetic foot surgery

Frequently Asked Questions About Diabetic Foot Ulcers

What is the difference between E11.621 and L97.401 in ICD-10 coding?

E11.621 codes the diabetes diagnosis with foot ulcer as a manifestation, capturing the underlying condition. L97.401 (and related codes) identifies the specific anatomical wound site and severity. Both codes should be used together for complete clinical documentation. The L97 code classifies the wound itself (location and depth), while E11.621 links it to the diabetic aetiology.

When should a diabetic foot patient be referred urgently in Singapore?

Urgent referral to a vascular or diabetic foot specialist at SGH, NUH, or Alexandra Hospital is indicated for: ABPI <0.5, Wagner Grade 3 with suspected osteomyelitis, Wagner Grade 4–5 gangrene, severe infection with systemic signs (SIRS), rapidly progressing cellulitis, or any new foot ulcer in a patient with known peripheral arterial disease.

How does Charcot neuroarthropathy differ from diabetic foot infection?

Charcot neuroarthropathy presents with a warm, swollen, erythematous foot — often confused with infection. The key distinction: Charcot is typically painless (due to neuropathy), lacks systemic signs of infection, and occurs in patients with intact skin. MRI and bone scan help differentiate. Offloading in a TCC is the cornerstone of Charcot management.

EMIS+ supplies evidence-based wound care dressings across Singapore. Browse our wound care range at emis.asia or contact our nursing team for product advice.

References

  1. International Working Group on the Diabetic Foot. IWGDF Guidelines 2023. iwgdfguidelines.org, 2023.
  2. Lipsky BA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections. Clin Infect Dis. 2023.
  3. Armstrong DG, et al. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:2367–2375.
  4. Wagner FW. The dysvascular foot: A system for diagnosis and treatment. Foot Ankle. 1981;2:64–122.
  5. Lavery LA, et al. WHS guidelines update: Diabetic foot ulcer treatment guidelines. Wound Repair Regen. 2024.
  6. Ministry of Health Singapore. National Population Health Survey 2022. MOH Singapore, 2022.
  7. NICE. Diabetic foot problems: prevention and management (NG19). London: NICE, 2015 (updated 2019).
  8. Chen L, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2024.
กลับไปยังบล็อก